Nucleophilic aromatic substitution on 3-aroyl-2-arylbenzothiophenes. Rapid access to raloxifene and other selective estrogen receptor modulators

Tetrahedron Letters

Volumn 40, Issue 4, 1999, Pages 675-678

  Schmid, Christopher R ^a   Sluka, James P ^a   Duke, Kristin M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR MODULATOR; RALOXIFENE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION KINETICS; DRUG MANUFACTURE; DRUG SYNTHESIS; HORMONE RECEPTOR INTERACTION; OSTEOPOROSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0033593554     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)02533-7     Document Type: Article

References (28)

1. (a) Grese, T. A.; Dodge, J. A. Curr. Pharm. Des. 1998, 4, 71-92.
2. (b) Bryant, H. U.; Dere, W. H. Proc. Soc. Exp. Biol. Med. 1998, 217, 45-52.
3. (a) Grese, T. A.; Sluka, J. P.; Bryant, H. U.; Cullinan, G. J.; Glasebrook, A. L.; Jones, C. D.; Matsumoto, K.; Palkowitz, A. D.; Sato, M.; Termine, J. D.; Winter, M. A.; Yang, N. N.; Dodge, J. A. Proc. Nat. Acad. Sci. U. S. A. 1997, 94, 14105-14110.
4. (b) Grese, T. A.; Dodge, J. A. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: New York. 1996; Vol. 31, pp. 181-190.
5. (c) Kauffman, R. F.; Bryant, H. U. Drug News Perspect. 1995, 8, 531-539.
6. (d) Evans, G. I.; Turner, R. T. Bone, 1995, 17, 1818-1908.
7. (a) Jones, C. D.; Jevikar, M. G.; Pike, A. J.; Peters, M. K.; Black, L. J.; Thompson, A. R.; Falcone, J. F.; Clemens, J. A. J. Med. Chem. 1984, 27, 1057-1066.
8. (b) Delmas, P. E.; Bjarnason, N. H.; Mitlak, B. H.; Ravoux, A-C.; Shah, A. S.; Huster, W. J.; Draper, M.; Christiansen, C. N. Engl. J. Med. 1997, 337, 1641-1647.
9. (c) Draper, M. W.; Flowers, D. E.; Huster, W. J.; Neild, J. A.; Harper, K. D.; Arnaud, C. J. Bone Mineral Res. 1996, II, 835-842.
10. (a) Grese, T. A.; Pennington, L. D.; Sluka, J. P.; Adrian, M. D.; Cole, H. W.; Fuson, T. R.; Magee, D. E.; Phillips, D. L.; Rowley, E. R.; Shetler, P. K.; Short, L. L.; Venugopalan, M.; Yang, N. N.; Sato, M.; Glasebrook, A. L.; Bryant, H. U. J. Med. Chem., 1998, 41, 1272-1283.
11. (b) Palkowitz, A. D.; Glasebrook, A. L.; Thrasher, K. J.; Hauser, K. L.; Short, L. L.; Phillips, D. L.; Muehl, B. S.; Sato, M.; Shetler, P. K.; Cullinan, G. J.; Pell, T. R.; Bryant, H. U. J. Med. Chem. 1997, 40, 1407-1416.
12. (c) Grese, T. A.; Cho, S.; Finley, D. A.; Godfrey, A. G.; Jones, C. D.; Lugar, C. W. III; Martin, M. J.; Matsumoto, K.; Pennington, L. D.; Winter, M. A.; Adrian, M. D.; Cole, H. W.; Magee, D. E.; Phillips, D. L.; Rowley, E. R.; Short, L. L.; Glasebrook, A. L.; Bryant, H. U. J. Med. Chem. 1997, 40, 146-167.
13. (d) Martin, M. J.; Grese, T. A.; Glasebrook, A. L.; Matsumoto, K.; Pennington, L. D.; Phillips, D. L.; Short, L. L. Bioorg. Med. Chem. Lett. 1997, 7, 887-892.
14. (e) Grese, T. A.; Cho, S.; Bryant, J. U.; Cole, H. W.; Glasebrook, A. L.; Magee, D. E.; Phillips, D. L.; Rowley, E. R.; Short, L. L. Bioorg. Med. Chem. Lett. 1996, 6, 201-206.
15. (e) Cameron, K. O.; Da Silva-Jardine, P.; Larson, E. R.; Hauske, J. R.; Rosati, R. L. PCT Int'l Appl. WO9510513.
16. (a) Godfrey, A. G. U.S. Patent 5,466,810, 1995; Chem. Abstr. 1996, 124, 175,813
17. (b) Godfrey, A. G. U.S. Patent 5,420,349, 1995; Chem. Abstr. 1995, 123, 111,843.
18. All new compounds exhibited satisfactory PMR, CMR, IR and analytical (elemental analysis or exact mass) data.
19. rd Ed. Wiley-Interscience: New York, 1985, p. 585
20. (b) Bernasconi, C. F. Chimia, 1980, 34, 1-11.
21. (c) Yeager, G.W.; Schissel, D. N. Synthesis, 1991, 63-68.
22. NAr has been used on a highly activated perfluorobenzoyl group to prepare a benzothiophene-based reagent for photoaffinity labelling of the estrogen receptor. See (d) Pinney, K. G.; Katzenellenbogen, J. A. J. Org. Chem. 1991, 56, 3125-3133.
23. NAr conditions employing dipolar aprotic solvents on substrates of similar reactivity have recently appeared. See (e) Berge, J.; Moore, G. N. Synlett, 1994, 3, 187-188.
24. (f) Ziegler, C. B.; Curran, W. V.; Kuck, N. A.; Harris, S. M.; Lin, Y-I J. Heterocydic Chem., 1989, 26, 1141.
25. (g) Idoux, J. P.; Madenwald, M. L.; Garcia, B. S.; Chu, D-L; Gupton, J. T. J. Org. Chem., 1985, 50, 1876.
26. The biological activity of 4f and 4g will be reported separately.
27. Smith, W. J. III; Sawyer, J. S. Tetrahedron Lett. 1996, 37, 299-302.
28. Peters, M. L. U. S. Patent 4,380,635, 1983.